Home Impladent

Impladent

acquired
-
Developer of Synthetic Absorbable Bone Grafts

Basic Information

Impladent develops and sells a series of innovative and affordable regenerative materials, including bone grafting products and absorbable membranes. For over 30 years, Impladent has been recognized as a leader in the innovation and development of synthetic absorbable bone grafts. In 1985, Impladent introduced OsteoGen® Synthetic Bioactive Resorbable Graft (SBRG) for bone augmentation and alveolar bone defect repair. The non-ceramic crystals of OsteoGen® are physically, chemically, and crystallographically similar to human trabecular bone, making the product equivalent to pure allogeneic bone. Recently, Impladent launched the OsteoGen® Bone Graft Plug, a one-step solution for alveolar bone preservation without the need for a membrane. Impladent is committed to developing regenerative products that meet the needs and interests of doctors while considering patient safety and comfort.
Impladent, Ltd.
NewYork,United States of America
15~50 people
January 01, 1985
--